Paragon Genomics

BiotechnologySeries AHayward, USparagongenomics.com

Latest round

Series A

Last raised

Sep 2017

Total raised

$8M

Investors

5

About Paragon Genomics

Paragon Genomics, Inc.Founded in 2015 by Tao Chen and Zhitong Liu, Paragon Genomics, Inc. is headquartered in Hayward, US. The company focuses on targeted genomic testing and has undergone no significant changes in strategy.Paragon Genomics offers advanced genomic testing solutions, including its CleanPlex® Multiplex PCR-Based Target Enrichment and Library Preparation Kits for amplicon sequencing. These products facilitate targeted DNA and RNA sequencing for various applications, including infectious diseases and precision oncology.The company generates revenue primarily through direct sales of its CleanPlex® products and custom next-generation sequencing (NGS) panels, focusing on B2B partnerships. The company is developing new products aimed at improving genomic testing efficacy and aims to penetrate several international markets by 2025.

Who invested in Paragon Genomics

5 investors across 1 round

See all investors in Paragon Genomics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 12, 2017

    Amount

    $8M

    Investors

    Locked

Questions about Paragon Genomics

Who invested in Paragon Genomics?

Paragon Genomics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Paragon Genomics raised?

Paragon Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Paragon Genomics last raise money?

Paragon Genomics's most recent round on record is a Series A, in Sep 2017.

What does Paragon Genomics do?

Paragon Genomics is a biotechnology company.

Where is Paragon Genomics headquartered?

Paragon Genomics is headquartered in Hayward, US.

Which VCs invest in companies like Paragon Genomics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Paragon Genomics's stage. Their profiles are linked below.

Raising like Paragon Genomics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.